Aziyo Biologics Inc. (AZYO)
NASDAQ: AZYO
· Real-Time Price · USD
1.49
0.03 (2.05%)
At close: Sep 06, 2023, 9:59 PM
Aziyo Biologics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -47.3M | -65.87M | -62.25M | -37.83M | -47.09M | -24.35M | -33.95M | -32.72M | -32.9M | -36.52M | -34.93M | -27.91M | -24.83M | -21.12M | -19.54M | -22.33M |
Depreciation & Amortization | 4.17M | 4.14M | 3.27M | 2.68M | 2.76M | 2.84M | 3.77M | 3.75M | 3.73M | 3.73M | 3.73M | 3.73M | 3.73M | 3.74M | 3.78M | 3.82M |
Stock-Based Compensation | 10.65M | 12.22M | 11.01M | 5.17M | 4.08M | 2.15M | 2.44M | 3.23M | 3.65M | 3.85M | 4.55M | 3.96M | 3.54M | 3.16M | 2.21M | 1.4M |
Other Working Capital | -6.66M | -6.66M | -6.66M | -4.94M | 1.57M | -1.34M | 1.82M | 1.81M | 457K | 3.64M | 332K | 1.42M | 642K | -1.48M | 403K | -702K |
Other Non-Cash Items | 5.86M | 6.52M | 13.86M | 481K | 4.02M | 37K | 734K | -1.45M | -1.63M | 3.05M | 2.74M | -272K | -254K | -250K | 3.18M | 6.22M |
Deferred Income Tax | -834K | -845K | -845K | 823K | 823K | 834K | 834K | n/a | n/a | n/a | n/a | -3.03M | -3.03M | -2.8M | -462K | 2.57M |
Change in Working Capital | -7.88M | -7.88M | -7.88M | -1.76M | 3.22M | 5.69M | 7.85M | 7.95M | 5.71M | 3.32M | 3.75M | 2.88M | 2.38M | 50K | -2.2M | -4.88M |
Operating Cash Flow | -35.33M | -27.1M | -18.53M | -6.13M | -7.87M | -13.11M | -18.32M | -19.25M | -21.43M | -22.58M | -20.16M | -17.62M | -15.45M | -14.43M | -12.56M | -15.76M |
Capital Expenditures | 280K | 280K | 280K | -72K | -267K | -401K | -518K | -688K | -540K | -431K | -411K | -272K | -369K | -459K | -798K | -709K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -1.43M | -1.31M | -1.03M | -560K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -1.15M | -1.03M | -754K | -632K | -267K | -401K | -518K | -688K | -540K | -431K | -411K | -272K | -369K | -459K | -798K | -709K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 41.25M | 41.77M | 28.49M | 11.51M | 129K | 14.4M | 11.62M | 9.55M | 8.54M | 8.48M | 8.71M | 9.57M | 6.71M | 35.87M | 40.68M | 46.35M |
Financial Cash Flow | 41.25M | 41.77M | 28.49M | 11.51M | 129K | 14.4M | 11.62M | 9.55M | 8.54M | 8.48M | 8.71M | 9.57M | 6.71M | 35.87M | 40.68M | 46.35M |
Net Cash Flow | 16.36M | 25.22M | 20.79M | 4.75M | -8.01M | 883K | -7.21M | -10.39M | -13.44M | -14.53M | -11.86M | -8.33M | -9.1M | 20.98M | 27.33M | 29.88M |
Free Cash Flow | -35.05M | -26.82M | -18.25M | -6.2M | -8.13M | -13.51M | -18.83M | -19.94M | -21.97M | -23.01M | -20.57M | -17.89M | -15.81M | -14.89M | -13.36M | -16.47M |